Addressing the Lack of Clarity About Administering Surfactant in Preterm Infants With Respiratory Distress Syndrome Treated With Noninvasive Respiratory Support

JAMA Pediatr. 2022 Feb 1;176(2):121-122. doi: 10.1001/jamapediatrics.2021.4098.
No abstract available

MeSH terms

  • Humans
  • Infant, Premature*
  • Practice Guidelines as Topic*
  • Respiration, Artificial*
  • Respiratory Distress Syndrome, Newborn / prevention & control
  • Respiratory Distress Syndrome, Newborn / therapy*
  • Surface-Active Agents / administration & dosage*

Substances

  • Surface-Active Agents